Bluestone Jeffrey bought GILD
January 20, 2026 · Form 4 insider transaction
Bluestone Jeffrey bought 5,000 shares of Gilead Sciences, Inc. at $67.45 per share, a transaction worth $337.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$67.45
Total value
$337.3K
InsiderBluestone Jeffrey
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after13,920
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.